Man Group PLC Dr Reddys Laboratories LTD Transaction History

Man Group PLC

$49.7 Billion
Q2 2025

A detailed history of Man Group PLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Man Group PLC holds 43,334 shares of RDY stock, worth $638,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,334

Previous 74,540 41.86%

Holding current value

$638,309

Previous $983,000 33.77%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$12.36 - $16.17 $385,706 - $504,601	-31,206 Reduced 41.86%	43,334 $651,000
Q1 2025 May 15, 2025	SELL	$12.53 - $15.81 $1.03 Million - $1.3 Million	-82,426 Reduced 52.51%	74,540 $983,000
Q4 2024 Feb 14, 2025	SELL	$13.99 - $79.75 $721,506 - $4.11 Million	-51,573 Reduced 24.73%	156,966 $2.48 Million
Q3 2024 Nov 14, 2024	BUY	$75.41 - $84.21 $6.63 Million - $7.41 Million	87,964 Added 72.95%	208,539 $16.6 Million
Q2 2024 Aug 14, 2024	SELL	$68.26 - $76.19 $39.9 Million - $44.6 Million	-584,988 Reduced 82.91%	120,575 $9.19 Million
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $4.02 Million - $4.63 Million	-59,630 Reduced 7.79%	705,563 $51.8 Million
Q4 2023 Feb 14, 2024	BUY	$64.27 - $69.9 $854,598 - $929,460	13,297 Added 1.77%	765,193 $53.2 Million
Q3 2023 Nov 14, 2023	BUY	$61.9 - $72.77 $36.9 Million - $43.4 Million	596,410 Added 383.58%	751,896 $50.3 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $6.44 Million - $7.62 Million	120,753 Added 347.66%	155,486 $9.81 Million
Q4 2022 Feb 14, 2023	SELL	$51.15 - $57.45 $321,017 - $360,556	-6,276 Reduced 15.3%	34,733 $1.8 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $4,990 - $5,732	-100 Reduced 0.24%	41,009 $2.15 Million
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $253,062 - $296,463	-5,100 Reduced 11.04%	41,109 $2.28 Million
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $381,333 - $515,475	7,900 Added 20.62%	46,209 $2.58 Million
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $136,850 - $154,675	-2,300 Reduced 5.66%	38,309 $2.51 Million
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $18,057 - $22,587	-300 Reduced 0.73%	40,609 $2.65 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $421,856 - $503,892	-6,791 Reduced 14.24%	40,909 $3.01 Million
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $127,556 - $160,776	2,200 Added 4.84%	47,700 $2.93 Million
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $2.92 Million - $3.32 Million	-46,600 Reduced 50.6%	45,500 $3.24 Million
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $2.79 Million - $3.94 Million	-54,376 Reduced 37.12%	92,100 $6.41 Million
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $2.07 Million - $2.86 Million	52,300 Added 55.53%	146,476 $7.77 Million
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $3.27 Million - $4.32 Million	94,176 New	94,176 $3.8 Million
Q1 2019 May 15, 2019	SELL	$35.77 - $40.57 $3.44 Million - $3.9 Million	-96,100 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $3.06 Million - $3.69 Million	96,100 New	96,100 $3.62 Million

Others Institutions Holding RDY

# of Institutions

259

Shares Held

93.2M

Call Options Held

Put Options Held

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.45B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account